We are live on ! Find out more
ADAP

Adaptimmune Therapeutics

Delisted

ADAP was delisted on the 27th of October, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
MCMC
1
Matrix Capital Management Company
New Hampshire
$201M
NMC
2
NEA Management Company
Maryland
$88.3M
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$66.3M +$5.06M +1,128,061 +10%
BBA
4
Baker Bros. Advisors
New York
$50.8M
Capital World Investors
5
Capital World Investors
California
$41.4M
PHS
6
PFM Health Sciences
California
$22.8M +$3.48M +775,674 +21%
Citadel Advisors
7
Citadel Advisors
Florida
$13.9M +$11.4M +2,540,526 +1,687%
RSCM
8
Rock Springs Capital Management
Maryland
$11.3M +$2.89M +644,788 +42%
JP Morgan Chase
9
JP Morgan Chase
New York
$8.25M -$1.17M -260,062 -14%
Millennium Management
10
Millennium Management
New York
$8.19M +$2.94M +654,434 +70%
Fidelity Investments
11
Fidelity Investments
Massachusetts
$8.16M -$4 -1 -0%
Marshall Wace
12
Marshall Wace
United Kingdom
$8.03M +$6.97M +1,553,800 New
BlackRock
13
BlackRock
New York
$6.52M +$1.25M +279,478 +28%
ECM
14
Endurant Capital Management
California
$4.74M -$2.79M -621,947 -40%
Rafferty Asset Management
15
Rafferty Asset Management
New York
$3.83M -$351K -78,200 -10%
Bank of America
16
Bank of America
North Carolina
$3.79M +$3.23M +719,108 +5,537%
State Street
17
State Street
Massachusetts
$2.94M +$1.38M +307,627 +119%
GCP
18
GSA Capital Partners
United Kingdom
$2.51M -$128K -28,606 -6%
EP
19
Eversept Partners
New York
$2.3M +$2M +444,887 New
RG
20
Rathbones Group
United Kingdom
$2.24M
SSA
21
Schonfeld Strategic Advisors
New York
$1.81M -$27.7K -6,170 -2%
Morgan Stanley
22
Morgan Stanley
New York
$1.73M -$8.76M -1,953,560 -85%
Goldman Sachs
23
Goldman Sachs
New York
$1.71M -$228K -50,783 -13%
Balyasny Asset Management
24
Balyasny Asset Management
Illinois
$1.34M +$1.16M +259,413 New
Susquehanna International Group
25
Susquehanna International Group
Pennsylvania
$1.16M +$508K +113,204 +103%